Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference Jan. 28 & 29 in Atlantic City, NJ
Rhea-AI Summary
BIO-key (NASDAQ: BKYI) will present at the DealFlow Discovery investor conference on Jan 28–29, 2026 at the Borgata hotel in Atlantic City, New Jersey.
CEO Mike DePasquale will deliver a presentation and be available for 1-on-1 meetings; presentation details will be posted on the conference website in January. Institutional investors, family offices and high-net-worth investors may register to attend at no cost via the DealFlow Discovery registration page.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, BKYI declined 0.83%, reflecting a mild negative market reaction. This price movement removed approximately $57K from the company's valuation, bringing the market cap to $7M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus 1 Down
Peers showed mixed moves, with SUGP up 6.14%, VRME up 2.79%, and IVDA, GFAI, SPCB down between about 1–2%, indicating stock-specific rather than broad sector momentum.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Conference participation | Positive | +0.6% | Showcasing passwordless and biometric IAM innovations at Gartner IAM Summit. |
| Nov 17 | Strategic partnership | Positive | +2.9% | Partnership with SAVIS Group to distribute biometric IAM solutions in Vietnam. |
| Nov 14 | Earnings and outlook | Negative | -2.4% | Q3 2025 results with lower revenue and net loss but growth initiatives. |
| Nov 12 | Strategic partnership | Positive | +11.3% | VaporVM partnership to expand IAM and biometric solutions across MEA region. |
| Nov 10 | Conference showcase | Positive | -16.9% | Biometric identity demos at Africa Tech Festival coinciding with sharp price drop. |
Recent news has produced mixed reactions: partnerships often saw positive moves, while event-focused announcements showed both gains and sharp selloffs.
Over the last few months, BIO-key has combined product showcases, partnerships, and financial updates. In November 2025, partnerships with SAVIS Group and VaporVM to expand biometric IAM offerings into Vietnam and the Middle East/Africa saw positive reactions of 2.87% and 11.31%. By contrast, showcasing at Africa Tech Festival on Nov 10 coincided with a -16.94% move. Q3 2025 results on Nov 14 highlighted declining revenue and a net loss, with a modest share price decline. The current investor-conference appearance continues the pattern of visibility-focused announcements.
Market Pulse Summary
This announcement highlights BIO-key’s continued focus on investor outreach, with its CEO presenting at the DealFlow Discovery Conference on January 28–29. It follows recent partnerships in Vietnam and the Middle East/Africa and Q3 2025 results that combined revenue pressure with growth initiatives. Investors may watch how conference interactions translate into new relationships or deals, while also monitoring balance-sheet developments, warrant-related resale activity, and progress on maintaining Nasdaq listing compliance.
Key Terms
biometric technical
identity and access management technical
saas financial
passwordless technical
phish-resistant authentication technical
AI-generated analysis. Not financial advice.
ATLANTIC CITY, N.J. and HOLMDEL, N.J., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant authentication, will participate at the DealFlow Discovery Conference Wednesday and Thursday, January 28th and 29th at the Borgata hotel in Atlantic City, New Jersey. Institutional investors, family offices and high-net-worth investors are invited to attend at no cost.
BIO-key CEO Mike DePasquale will present at DealFlow Discovery and will be available for 1-on-1 meetings throughout the event. BIO-key’s presentation details will be posted on DealFlow’s website in January.
Registration:
Click here: https://dealflowdiscoveryconference.com/registration/ to register for the Discovery Conference.
About The DealFlow Discovery (www.dealflowdiscoveryconference.com)
The DealFlow Discovery Conference is where high-growth companies come to be discovered. Formerly known as The Microcap Conference, the event has been expanded to include both publicly traded microcaps and qualified private companies across a variety of high-growth sectors.
Organized by DealFlow Events, the conference brings together hundreds of companies, investors, and dealmakers for two days of company presentations, expert discussions on raising capital, unlimited 1-on-1 meetings, interactive sessions and networking opportunities. The Discovery Conference delivers a high visibility platform for companies to showcase their value propositions to a broad base of prospective investors.
Keynote presentations and panel discussions led by renowned industry figures will provide insights on business, investing, entrepreneurial success, and other trends in US equity markets, from capital formation to regulatory updates, tailored to the public microcap and private market communities.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key: | |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800